Vivos Therapeutics, Inc. (VVOS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.01M | -3.81M | -4.16M | -3.49M | -3.8M | -2.94M | -4.19M | -3.05M | -2.52M | -2.75M | -2.8M | -2.86M |
| Operating CF Margin % | -116.9% | -99.69% | -61.34% | -91.47% | -125.86% | -79.5% | -108.47% | -75.19% | -73.59% | -84.61% | -84.82% | -84.21% |
| Operating CF Growth % | -58.32% | -29.66% | 0.62% | -14.63% | -50.87% | -6.99% | -49.54% | -6.61% | 28.91% | 8.4% | 52.07% | 38.69% |
| Net Income | -7.75M | -6.95M | -5.4M | -5.01M | -3.86M | -2.83M | -2.62M | -1.93M | -3.76M | -4.26M | -2.09M | -5.53M |
| Depreciation & Amortization | 454K | 442K | 384K | 306K | 177K | 144K | 146K | 145K | 146K | 149K | 149K | 148K |
| Stock-Based Compensation | 151K | 47K | 55K | 242K | 317K | 57K | 142K | 270K | 299K | 152K | 189K | 459K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192K | 0 | -5.94M |
| Other Non-Cash Items | 654K | -100K | 0 | 100K | 0 | 5K | -2.62M | 26K | 0 | 112K | -1.76M | 6.99M |
| Working Capital Changes | 482K | 2.75M | 799K | 871K | -426K | -319K | 757K | -1.56M | 802K | 906K | 713K | 1.01M |
| Change in Receivables | -188K | 553K | -501K | 19K | -288K | 24K | -59K | 131K | -324K | 26K | 99K | -6K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -801K | 1.46M |
| Change in Payables | 318K | -424K | 340K | 499K | 109K | 22K | -953K | -471K | 354K | 616K | 204K | -170K |
| Cash from Investing | -18K | -1.58M | 83K | -5.91M | -122K | -165K | -192K | -60K | -151K | -165K | -154K | -245K |
| Capital Expenditures | -18K | -893K | 893K | -771K | -122K | -165K | 211K | -60K | -151K | -165K | -154K | -245K |
| CapEx % of Revenue | 0.35% | 23.35% | 13.17% | 20.18% | 4.05% | 4.46% | 5.47% | 1.48% | 4.42% | 5.08% | 4.67% | 7.22% |
| Acquisitions | 0 | -50K | 5.13M | -5.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -638K | -5.95M | 0 | 0 | 0 | -403K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.11M | 4.33M | 2.76M | 11.46M | 0 | 3.05M | 3.79M | 7.4M | 3.63M | 3.57M | 0 | 0 |
| Debt Issued (Net) | 980K | 1.53M | -531K | 9.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 5.13M | 2.8M | 3.29M | 1.82M | 0 | 3.5M | 3.79M | 7.4M | 3.63M | 4M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | -446K | 0 | 0 | 0 | -432K | 0 | 0 |
| Net Change in Cash | 81K | -1.06M | -1.31M | 2.06M | -3.92M | -51K | -592K | 4.29M | 968K | 655K | -2.95M | -3.1M |
| Free Cash Flow | -6.01M | -4.71M | -3.27M | -4.26M | -3.92M | -3.1M | -3.98M | -3.11M | -2.67M | -2.91M | -2.95M | -3.1M |
| FCF Margin % | -116.9% | -123.04% | -48.18% | -111.65% | -129.91% | -83.96% | -103.01% | -76.67% | -78.01% | -89.69% | -89.49% | -91.43% |
| FCF Growth % | -53.39% | -51.53% | 17.81% | -37.23% | -46.91% | -6.59% | -34.6% | -0.13% | 29.41% | 8.97% | 50.29% | 39.93% |
| FCF per Share | -0.41 | -0.51 | -0.30 | -0.47 | -0.46 | -0.53 | -0.60 | -0.96 | -1.16 | -1.59 | -2.47 | -2.59 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.55x | 0.77x | 0.70x | 0.98x | 1.04x | 1.60x | 1.58x | 0.67x | 0.65x | 1.34x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |